Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
---|---|---|---|---|---|
Revenue | -- | -- | -- | 1.03B | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | -- | -- | -- | 1.03B | |
Cost of Revenue | -- | -- | -- | 720.74M | |
Gross Profit | -- | -- | -- | 308.45M | |
SG&A Expenses | -- | -- | -- | 257.70M | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -237.60K | |
Total Operating Expenses | -- | -- | -- | 978.20M | |
Operating Income | -- | -- | -- | 50.99M | |
Income Before Tax | -- | -- | -- | 24.41M | |
Income Tax Expenses | -- | -- | -- | 10.93M | |
Earnings from Continuing Operations | -- | -- | -- | 13.48 | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -- | -- | -- | 13.48M | |
EBIT | -- | -- | -- | 50.99M | |
EBITDA | -- | -- | -- | 109.77M | |
EPS Basic | -- | -- | -- | 0.03 | |
Normalized Basic EPS | -- | -- | -- | 0.04 | |
EPS Diluted | -- | -- | -- | 0.03 | |
Normalized Diluted EPS | -- | -- | -- | 0.04 | |
Average Basic Shares Outstanding | -- | -- | -- | 1.63B | |
Average Diluted Shares Outstanding | -- | -- | -- | 1.63B | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |